HER2-positive Breast Cancer Project Initiated by Investigators
NCT05346328
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Injection of A166
Sponsor
Fudan University